- Main
Phenotypic discovery of GABAA receptor-mediated general anesthetics with analgesic activity
- McCarroll, Matthew N;
- Weinrich, Jarret AP;
- Marinas, Alyssa H;
- Dombroski, Amanda;
- Pierce, Lain X;
- Gu, Xilin;
- Larmore, Megan J;
- Teng, Jinfeng;
- Sisko, Elizabeth J;
- Andolina, Christopher;
- Da Luz, Ricardo;
- Zhang, Ralph;
- Taylor, Jack C;
- Myers-Turnbull, Douglas;
- Helsell, Cole;
- Carbajal, Amanda;
- Kinser, Reid;
- Jewell, Madison;
- Bhardwaj, Karnika;
- Rodriguez-Rosado, Sian;
- Ali, Israr;
- Deuis, Jennifer;
- Andersson, Asa;
- Bean, Bruce P;
- Vetter, Irina;
- Glinin, Timofey;
- Roman, Sanziana A;
- Koh, James;
- Bokoch, Michael P;
- Shoichet, Brian K;
- Kokel, David;
- Hibbs, Ryan E;
- Basbaum, Allan I;
- Sello, Jason K
Published Web Location
https://doi.org/10.1038/s41467-026-79384-xAbstract
General anesthetics are essential for invasive medical procedures; however, there remains a need for safer agents. Using a bespoke 96-well-plate format platform enabling high-throughput imaging of larval zebrafish behavior, we screen 12,000 compounds and identify an isoxazole chemotype that phenocopies the intravenous anesthetics etomidate and propofol. Its optimization via medicinal chemistry yields an anesthetic that we call nidradine. This anesthetic is efficacious in both zebrafish and mice and lacks the problematic adrenal suppression characteristic of etomidate. Mechanistic studies using electrophysiology and structural biology reveal that nidradine, like etomidate and propofol, is a positive allosteric modulator of the GABAA receptor. Remarkably, behavioral assays in mice demonstrate that nidradine differs from most general anesthetics in that it also produces analgesia at subsedative doses.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.